These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31903639)

  • 1. Sialic acids rather than glycosaminoglycans affect normal and sickle red blood cell rheology by binding to four major sites on fibrinogen.
    Gondelaud F; Connes P; Nader E; Renoux C; Fort R; Gauthier A; Joly P; Ricard-Blum S
    Am J Hematol; 2020 Apr; 95(4):E77-E80. PubMed ID: 31903639
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of neuraminidase on the characteristics of microrheology of red blood cells.
    Wen Z; Yao W; Xie L; Yan ZY; Chen K; Ka W; Sun D
    Clin Hemorheol Microcirc; 2000; 23(1):51-7. PubMed ID: 11214713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell aggregation, aggregate strength and oxygen transport potential of blood are abnormal in both homozygous sickle cell anemia and sickle-hemoglobin C disease.
    Tripette J; Alexy T; Hardy-Dessources MD; Mougenel D; Beltan E; Chalabi T; Chout R; Etienne-Julan M; Hue O; Meiselman HJ; Connes P
    Haematologica; 2009 Aug; 94(8):1060-5. PubMed ID: 19644138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pluronic F-68 reduces the endothelial adherence and improves the rheology of liganded sickle erythrocytes.
    Smith CM; Hebbel RP; Tukey DP; Clawson CC; White JG; Vercellotti GM
    Blood; 1987 Jun; 69(6):1631-6. PubMed ID: 3580571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheological characteristics of desialylated erythrocytes in relation to fibrinogen-induced aggregation.
    Maeda N; Imaizumi K; Sekiya M; Shiga T
    Biochim Biophys Acta; 1984 Sep; 776(1):151-8. PubMed ID: 6477901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased blood viscosity and red blood cell aggregation in a patient with sickle cell anemia and smoldering myeloma.
    Lemonne N; Connes P; Romana M; Vent-Schmidt J; Bourhis V; Lamarre Y; Etienne-Julan M
    Am J Hematol; 2012 Nov; 87(11):E129. PubMed ID: 22930533
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrinogen interaction with the red blood cell membrane.
    Saldanha C
    Clin Hemorheol Microcirc; 2013; 53(1-2):39-44. PubMed ID: 22960295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of HMG-CoA reductase inhibitors on red blood cell membrane lipids and haemorheological parameters, in patients affected by familial hypercholesterolemia.
    Martinez M; Vaya A; Marti R; Gil L; Lluch I; Carmena R; Aznar J
    Haemostasis; 1996 Oct; 26 Suppl 4():171-6. PubMed ID: 8979121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of Daflon 500 mg on the hemorheological disorders in diabetes.
    Lacombe C; Lelievre JC; Bucherer C; Grimaldi A
    Int Angiol; 1989; 8(4 Suppl):45-8. PubMed ID: 2632648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ox erythrocyte agglutinability. 4. The effect of neuraminidase treatment on the agglutinability of cells and ghosts.
    Green JR; Spooner RL
    Anim Blood Groups Biochem Genet; 1977; 8(1):25-32. PubMed ID: 900580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving abnormal hemorheological parameters in aging guinea pigs by water-soluble extracts of Salvia miltiorrhiza Bunge.
    Hou WC; Tsay HS; Liang HJ; Lee TY; Wang GJ; Liu DZ
    J Ethnopharmacol; 2007 May; 111(3):483-9. PubMed ID: 17223298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the effects of major ozone autohemotherapy application on erythrocyte deformability and aggregation.
    Akbudak IH; Kucukatay V; Kilic-Erkek O; Ozdemir Y; Bor-Kucukatay M
    Clin Hemorheol Microcirc; 2019; 71(3):365-372. PubMed ID: 29914015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of alcian blue effect on erythrocyte aggregation].
    Bulegenov KE; Balmukhanov BS
    Kardiologiia; 1993; 33(4):42-4. PubMed ID: 7933792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemorheological changes caused by lead exposure.
    Kim CB; Shin S; Song SH
    Clin Hemorheol Microcirc; 2013; 55(3):341-8. PubMed ID: 23076008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte deformability and aggregation in homozygous sickle cell disease.
    Vayá A; Collado S; Dasí MA; Pérez ML; Hernandez JL; Barragán E
    Clin Hemorheol Microcirc; 2014; 58(4):497-505. PubMed ID: 23603322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte/endothelial interactions in the pathogenesis of sickle-cell disease: a "real logical" assessment.
    Hebbel RP; Eaton JW; Steinberg MH; White JG
    Blood Cells; 1982; 8(1):163-73. PubMed ID: 7115974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of blood rheology in sickle cell disease.
    Connes P; Alexy T; Detterich J; Romana M; Hardy-Dessources MD; Ballas SK
    Blood Rev; 2016 Mar; 30(2):111-8. PubMed ID: 26341565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of sialic acid in erythrocyte survival.
    Durocher JR; Payne RC; Conrad ME
    Blood; 1975 Jan; 45(1):11-20. PubMed ID: 803103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Poloxamer 188 on red blood cell membrane properties in sickle cell anaemia.
    Sandor B; Marin M; Lapoumeroulie C; Rabaï M; Lefevre SD; Lemonne N; El Nemer W; Mozar A; Français O; Le Pioufle B; Connes P; Le Van Kim C
    Br J Haematol; 2016 Apr; 173(1):145-9. PubMed ID: 26846309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemorheological and antioxidant effects of Ascovertin in patients with sclerosis of cerebral arteries.
    Plotnikov MB; Plotnikov DM; Aliev OI; Maslov MY; Vasiliev AS; Alifirova VM; Tyukavkina NA
    Clin Hemorheol Microcirc; 2004; 30(3-4):449-52. PubMed ID: 15258384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.